European private equity firm Silverfleet Capital is to buy Ipes, a provider of fund administration and outsourcing services to the private equity industry, from RJD Partners. The deal is valued at 50 million pounds ($76.5 million).

European private equity firm Silverfleet Capital has promoted three of its investment team. Mark Piasecki, who is based in London, has been promoted to principal. Robert Knight, also based in London, and Cyril Bourdarot who is based in Paris, have become investment executives.

Aesica Pharmaceuticals, a pharmaceutical contract manufacturer backed by European private equity firm Silverfleet Capital has appointed David Greensmith as non-executive chairman. Greensmith’s previous executive roles include managing director of Fujifilm Imaging Colorants and COO of Avecia Group. PRESS RELEASE One of the fastest growing businesses in the UK, Aesica Pharmaceuticals, the pharmaceutical contract manufacturer backed [...]

London-based Footwear retailer OFFICE, backed by European private equity firm Silverfleet Capital has appointed Allan Leighton as non-executive chairman. This is the second senior appointment to the board after Ian Findlay joined as finance director in September. PRESS RELEASE Young fashion footwear retailer OFFICE, backed by Silverfleet Capital the European private equity firm, today reported [...]

London-based private equity firm Silverfleet Capital has agreed a majority investment with Aesica Pharmaceuticals replacing that of LDC. Members of Aesica’s executive team will reinvest a significant amount of money for a large minority stake. Debt is being provided by Lloyds, HSBC and Yorkshire Bank.Headquartered near Newcastle, UK, Aesica has the expertise to both develop and manufacture primary (API) and secondary stage (finished product dosage forms) pharmaceuticals.

Buyout shop GTCR has completed its acquisition of Sterigenics International Inc., a provider of contract sterilization and ionization services for medical devices, food products and other applications. The firm bought Oak Brook, Illinois-based Sterigenics from Silverfleet Capital and PPM America Capital Partners. Terms were not released. Jefferies & Company, Bank of America Merrill Lynch and UBS advised GTCR on the transaction.

(Reuters) – Private equity firm Silverfleet Capital is seeking to sell Sterigenics, the Chicago-based firm whose gamma-ray sterilisation technology is used by medical device makers, sources familiar with the situation said on Thursday.

Silverfleet is hoping the business, which it bought in 2004, will fetch about $800 million and expects it will attract interest from private equity firms and trade bidders, the sources said.

Silverfleet declined comment. Sterigenics’s listed competitors include Steris Corp (STE.N) and Canada’s MDS Nordion (MDS.TO).

LONDON (Reuters) – Buyout house Montagu Private Equity is turning its attention to the disposal of Survitec after its sale of Kalle on Thursday showed returning appetite for deals in defensive sectors, sources said. Montagu has appointed investment bank NM Rothschild to examine options for safety equipment manufacturer Survitec, a source familiar with the situation [...]

LONDON (Reuters) – UK-based private equity group Silverfleet Capital has begun exclusive talks to buy German sausage casing maker Kalle Nalo from rival group Montagu Private Equity, the Financial Times newspaper reported on Friday in an unsourced story. Citing people “familiar with the situation” the paper said Silverfleet Capital, the former buy-out arm of Prudential, [...]

LONDON (Reuters) – Silverfleet Capital, formerly PPM Ventures, is finalising debt financing to back its proposed acquisition of German sausage casing maker Kalle Nalo from Montagu Private Equity, banking sources said on Friday. A group of seven or eight banks are currently working on the financing, three bankers said, adding that the loan was likely [...]